Erratum to “Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)” [Eur Urol Oncol 2021;4:543–52]
Title:
Erratum to “Phase 3 Randomized Controlled Trial of Androgen Deprivation Therapy with or Without Docetaxel in High-risk Biochemically Recurrent Prostate Cancer After Surgery (TAX3503)” [Eur Urol Oncol 2021;4:543–52]
Author:
Morris, Michael J. Mota, Jose Mauricio Lacuna, Kristine Hilden, Patrick Gleave, Martin Carducci, Michael A. Saad, Fred Cohn, Erica D. Filipenko, Julie Heller, Glenn Shore, Neal Armstrong, Andrew J. Scher, Howard I.